WASHINGTON -- Up to three scans using 18 F-fluorodeoxyglucose-enhanced positron emission tomography (FDG-PET) technology can be covered by Medicare for oncology treatment planning, the Centers for ...
FDG PET imaging measures glucose uptake in the brain. It has long served as a proxy for neuronal health—but is it? In the October 13 Science Translational Medicine, researchers led by Christian Haass ...
For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in ...
An earlier indication of whether chemotherapy benefits non-small cell lung cancer patients -- provided by positron emission tomography (PET) imaging -- can guide doctors in offering them better care, ...
Increased prostatic uptake of FDG is associated with a higher risk of Gleason 8 or higher disease. NIAGARA FALLS, Ont.—Fluorodeoxyglucose positron emission tomography (FDG-PET) findings can help ...
Prognostic significance of S100A4 expression in biliary tract cancers. Background: The role of F-18 FDG-PET/CT in gastric cancer is limited because of its low sensitivity. The sensitivity of F-18 ...
Researchers at Mayo Clinic have developed a new artificial intelligence tool that may streamline dementia diagnosis by identifying characteristic brain activity patterns in a single fluorodeoxyglucose ...
Unveiling consistency: A large-scale analysis of conference proceedings and subsequent publications in oncology clinical trials using large language models. This is an ASCO Meeting Abstract from the ...
18 F-FDG-PET/CT (F-FDG) appears to offer value for staging of cutaneous squamous cell carcinoma (cSCC), according to the results of a recent small, single-institution study. 1 F-FDG reliably detected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results